Beijing-based Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutical companies, announced that it has raised a US$15 million series B round of financing from Sequoia Capital China. Deep Intelligent Pharma was founded in 2017 by Li Xing, who has 12 years of working experience in multinational pharmaceutical […]

Sequoia Invests $15M In Chinese Healthcare AI Start-up Deep Intelligent Pharma appeared first on China Money Network.